Bio-Rad Labs (BIO) Tops Q2 EPS by 58c
Tweet
Share
E-mail
Get Alerts BIO Hot Sheet
Price: $296.11 -0.39%
EPS Growth %: -30.7%
Financial Fact:
Other (income) expense, net: -11.21M
Today's EPS Names:
CCEL, FEIM, PLG, More
EPS Growth %: -30.7%
Financial Fact:
Other (income) expense, net: -11.21M
Today's EPS Names:
CCEL, FEIM, PLG, More
Join SI Premium – FREE
Bio-Rad Labs (NYSE: BIO) reported Q2 EPS of $3.38, $0.58 better than the analyst estimate of $2.80. Revenue for the quarter came in at $691.1 million versus the consensus estimate of $682.62 million.
For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'
- Wells Fargo previews Q2 midstream earnings, favors PAA and TRGP
- Barclays upgrades CubeSmart, cuts Public Storage on relative valuation
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
